Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease

被引:6817
作者
Hansson, GK [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Dept Med, SE-17176 Stockholm, Sweden
关键词
D O I
10.1056/NEJMra043430
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this review article, Göran Hansson, a pioneer in the study of the role of inflammation in atherosclerosis and coronary artery disease, summarizes new ideas on the pathogenesis of acute coronary syndromes.
引用
收藏
页码:1685 / 1695
页数:11
相关论文
共 114 条
  • [71] A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation
    Massberg, S
    Brand, K
    Grüner, S
    Page, S
    Müller, E
    Müller, I
    Bergmeier, W
    Richter, T
    Lorenz, M
    Konrad, I
    Nieswandt, B
    Gawaz, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) : 887 - 896
  • [72] Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
    McCarey, DW
    McInnes, LB
    Madhok, R
    Hampson, R
    Scherbakova, O
    Ford, I
    Capell, HA
    Sattar, N
    [J]. LANCET, 2004, 363 (9426) : 2015 - 2021
  • [73] Oxidized low density lipoprotein and innate immune receptors
    Miller, YI
    Chang, MK
    Binder, CJ
    Shaw, PX
    Witztum, JL
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (05) : 437 - 445
  • [74] MACROPHAGE INFILTRATION IN ACUTE CORONARY SYNDROMES - IMPLICATIONS FOR PLAQUE RUPTURE
    MORENO, PR
    FALK, E
    PALACIOS, IF
    NEWELL, JB
    FUSTER, V
    FALLON, JT
    [J]. CIRCULATION, 1994, 90 (02) : 775 - 778
  • [75] Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
    Murray, CJL
    Lopez, AD
    [J]. LANCET, 1997, 349 (9063) : 1436 - 1442
  • [76] Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse
    Nakashima, Y
    Raines, EW
    Plump, AS
    Breslow, JL
    Ross, R
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) : 842 - 851
  • [77] Immunomodulation of atherosclerosis - Implications for vaccine development
    Nilsson, J
    Hansson, GK
    Shah, PK
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (01) : 18 - 28
  • [78] Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
    Nissen, SE
    Tuzcu, EM
    Schoenhagen, P
    Crowe, T
    Sasiela, WJ
    Tsai, J
    Orazem, J
    Magorien, RD
    O'Shaughnessy, C
    Ganz, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01) : 29 - 38
  • [79] Azithromycin for the secondary prevention of coronary heart disease events - The WIZARD study: A randomized controlled trial
    O'Connor, CM
    Dunne, MW
    Pfeffer, MA
    Muhlestein, JB
    Yao, L
    Gupta, S
    Benner, RJ
    Fisher, MR
    Cook, TD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (11): : 1459 - 1466
  • [80] IMMUNIZATION OF LOW-DENSITY-LIPOPROTEIN (LDL) RECEPTOR-DEFICIENT RABBITS WITH HOMOLOGOUS MALONDIALDEHYDE-MODIFIED LDL REDUCES ATHEROGENESIS
    PALINSKI, W
    MILLER, E
    WITZTUM, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) : 821 - 825